Aurobindo Pharma Foundation, a active private not for profit company, was established on 20 July 2020 in Hyderabad, Telangana, India. Engaging in animal health services within the veterinary sector, it holds CIN: U85200TG2020NPL141954. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 18 professional, Its leadership includes Nityananda Reddy Kambam (Director), Sivakumaran Meenakshisunderam (Director), Sarath Chandra Reddy Penaka (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.
U85200TG2020NPL141954
141954
20 July 2020
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aurobindo Pharma Foundation — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nityananda Reddy Kambam | Director | 20 Jul 2020 | Current |
| Sivakumaran Meenakshisunderam | Director | 20 Jul 2020 | Current |
| Sarath Chandra Reddy Penaka | Director | 20 Jul 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aurobindo Pharma Foundation, for the financial year ended 2023, experienced significant growth in revenue, with a 39.88% increase. The company also saw a substantial fall in profitability, with a 100% decrease in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2023, Aurobindo Pharma Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aurobindo Pharma Foundation has a workforce of 18 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurobindo Pharma Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurobindo Pharma Foundation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aurobindo Pharma Foundation last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Aurobindo Pharma Foundation has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
Progress on Nityananda Reddy Kambam was appointed as a Director was appointed as a Director on 20 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
The activity Sivakumaran Meenakshisunderam was appointed as a Director was appointed as a Director on 20 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
Progress on Sarath Chandra Reddy Penaka was appointed as a Director was appointed as a Director on 20 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
The activity Aurobindo Pharma Foundation was registered on 20 Jul 2020 with Roc Hyderabad & aged 5 years 4 months as per MCA records. was completed.
FDA: Aurobindo Pharma's manufacturing facility has incomplete and misleading documents. They also found issues with quality control and training. Equipment is not cleaned properly. Aurobindo says they will fix it. FDA inspected from Sept 19-27 and issued warning letter for other facility. Aurobindo's stock went down..
The CIN of Aurobindo Pharma Foundation is U85200TG2020NPL141954.
Aurobindo Pharma Foundation is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.
Aurobindo Pharma Foundation was incorporated on 20 July 2020.
The current directors of Aurobindo Pharma Foundation are
The primary industry of Aurobindo Pharma Foundation is Veterinary.
Aurobindo Pharma Foundation is unlisted.
The authorized capital of Aurobindo Pharma Foundation is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX